ETAOF — ETAO International Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $7.67m
- $58.06m
Annual income statement for ETAO International Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 2001-04-01T00:00:00.000Z | 20-F | 20-F |
| Standards: | — | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 53.3 | 58.1 |
| Cost of Revenue | |||
| Gross Profit | 0 | 16.3 | 19 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 0.318 | 62.7 | 955 |
| Operating Profit | -0.318 | -9.33 | -896 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.318 | -9.45 | -896 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.318 | -9.95 | -897 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Extraordinary Items | |||
| Net Income | -0.318 | -10.5 | -897 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.318 | -10.5 | -897 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.062 | -1.44 | -155 |
| Special Dividends per Share |